Data to be presented at the 2022 AACR annual meeting highlights the unique nature of post-chemotherapy derived gene expression signatures in stratifying patient outcomes
An integrated and agile approach enables the pharmaceutical CDMO industry to simplify manufacturing as it moves from primary care medicines to specialty medicines
MilliporeSigma to become the first company to offer a fully integrated ecosystem for advanced process technologies
The partnership demonstrates increasing adoption of tetra data to create unrestricted innovation
The new facility is scheduled to start operation in the first half of 2024
New high-throughput, no-wash assays contribute to the development, manufacture and quality control of safer, more effective biotherapeutics
The investment will significantly enhance the development of high-purity lipid systems, essential delivery systems for next generation nucleic acid drugs such as mRNA vaccines
Bayer will be setting up 27 telemedicine centres in 12 districts across 8 states with implementing partners Telerad RxDx and Piramal Swasthya
The plant is scheduled to come on stream in September 2024
The funding will accelerate the AI-driven healthcare company's market expansion into the global market and support new product development
Subscribe To Our Newsletter & Stay Updated
